MARKET

OASMY

OASMY

Oasmia Pharm
OTCMKTS

Real-time Quotes | Nasdaq Last Sale

1.500
+0.010
+0.67%
Closed 16:00 10/18 EDT
OPEN
1.500
PREV CLOSE
1.490
HIGH
1.500
LOW
1.500
VOLUME
100
TURNOVER
150
52 WEEK HIGH
5.10
52 WEEK LOW
0.9381
MARKET CAP
373.64M
P/E (TTM)
-13.3333
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of OASMY and other stocks commission-free!

Open a Webull account and fund it to get a free stock

OASMY News

  • LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors who Suffered Losses Exceeding $50,000 in Oasmia Pharmaceutical AB to Contact the Firm
  • Newsfile.09/04 15:30
  • Oasmia Pharmaceutical AB (OASM), Eagle Bancorp, Inc. (EGBN) & 3M Company (MMM) - Bronstein, Gewirtz & Grossman, LLC - Class Action Reminder
  • ACCESSWIRE.08/21 15:23
  • OASMIA INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Oasmia Pharmaceutical AB To Contact The Firm
  • GlobeNewswire.08/21 12:19
  • OASM CLASS ACTION DEADLINE: Hagens Berman Reminds Investors in Oasmia Pharmaceutical AB (OASM) of Upcoming Lead Plaintiff Deadline
  • ACCESSWIRE.08/21 01:05

More

Industry

Pharmaceuticals
-0.90%
Pharmaceuticals & Medical Research
-0.94%

Hot Stocks

Name
Price
%Change

About OASMY

Oasmia Pharmaceutical AB is a Sweden-based pharmaceutical company engaged in the field of human and veterinary oncology. The Company’s activities are divided into two segments: Human Health and Animal Health. The Human Health segment specializes in ovarian and breast cancer. The Animal Health area focuses on developing cancer treatments for dogs. Its drugs portfolio comprises six candidates: Paclical, Doxophos, Docecal and OAS-19, which are implemented in human treatment, as well as Paccal Vet-CA1 and Doxophos Vet, introduced in cancer in dogs. The Company’s medicines are based on the patented XR-17 excipient, which forms micelles with water-soluble substances. Furthermore, It cooperates with Abbott Laboratories, Pharmasyntez, Nippon Zenyaku Kogyo and Medison Pharma. The Company is a parent of Oasmia Global Supplies AB and Oasmia Animal Health AB.
More

Webull offers Oasmia Pharmaceutical AB (OASMY) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.